Search

Displaying results 9921 - 9930 of 10000 in total
  1. Drug

    Belrestotug

    go.drugbank.com/drugs/DB19066
    Investigational

    Belrestotug is under investigation in clinical trial NCT05565378 (A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/metastatic Non-small-cell Lung

  2. Drug

    alpha-Pyrrolidinononanophenone

    go.drugbank.com/drugs/DB05531
    Investigational

  3. Drug

    Dibrompropamidine

    go.drugbank.com/drugs/DB13548
    Experimental

    Categories: Biguanides and Amidines, Antiseptics and Disinfectants
  4. Drug

    GTX-758

    go.drugbank.com/drugs/DB14969
    Investigational

    GTX-758 is under investigation in clinical trial NCT01420861 (GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer).

  5. Drug

    Ecnoglutide

    go.drugbank.com/drugs/DB19019
    Investigational

    Ecnoglutide is under investigation in clinical trial NCT05813795 (A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity).

  6. Drug

    Nelonicline

    go.drugbank.com/drugs/DB19040
    Investigational

    Nelonicline is under investigation in clinical trial NCT01678755 (A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia).

  7. Drug

    MOR-22

    go.drugbank.com/drugs/DB17790
    Experimental

    MOR-22, a Natural human lymphoblastoid interferon-alpha, is currently being investigated to treat papillomavirus warts in the oral cavity of HIV-positive patients.

  8. Drug

    Bifemelane

    go.drugbank.com/drugs/DB13550
    Experimental

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  9. Drug

    AB192

    go.drugbank.com/drugs/DB06111
    Experimental

    AB192 is a DPP IV enzymatic activity inhibitor.

    Categories: Amino Acids, Peptides, and Proteins, Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, antagonists & inhibitors
  10. Drug

    Taranabant

    go.drugbank.com/drugs/DB06624
    Investigational

    Categories: Cannabinoids and similars, Hormones, Hormone Substitutes, and Hormone Antagonists